Answers are grounded in this paper and cite their sources.
Analyses of at-risk cognitively normal populations suggest that we can reliably measure the first signs of cognitive decline with the ADCS-PACC. These analyses also suggest the feasibility of secondary prevention trials.
No takes yet. Share an insight, caveat, or question.
Donohue et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: